[1] 马学功. 妇科肿瘤腹膜后淋巴清扫术后淋巴囊肿的防治进展[J]. 中华医学杂志, 2018, 98(3): 237-240.
[2] Weingold A B, Olivo E, Marino J. Pelvic lymphocyst: diagnosis and management [J]. Arch Surg, 1967, 95(2): 304-307.
[3] Achourl A, Huchon C, Bats A S, et al. Complications of lymphadenectomy for gynecologic cancer [J]. Eur J Surg Oncol, 2013, 39(1): 81-86.
[4] Kim H Y, Kim J W, Kim S H, et al. An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies [J]. Cancer Res Treat, 2004, 36(6): 377-383.
[5] Zikan M, Fischerova D, Pinkavova I, et al. A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer [J]. Gynecol Oncol, 2015, 137(2): 291-298.
[6] Togami S, Kawamura T, Fukuda M, et al. Risk factors for lymphatic complications following lymphadenectomy in patients with cervical cancer [J]. Jpn J Clin Oncol, 2018, 48(12): 1036-1040.
[7] Lv S, Wang Q, Zhao W, et al. A review of the postoperative lymphatic leakage [J]. Oncotarget, 2017, 8(40): 69062-69075.
[8] 王 宇, 温宏武, 李 琳, 等. 妇科恶性肿瘤术后盆腔淋巴囊肿的诊疗进展 [J]. 中国医刊, 2019, 37(7): 719-722.
[9] 顾永忠, 张向宁. 妇科盆腔淋巴结清扫术后淋巴囊肿的防治 [J]. 中国实用妇科与产科杂志, 2008, 9: 712-714.
[10] 叶 国,黄 浩. 腹腔镜盆腹腔淋巴结清扫术后淋巴囊肿的诊治进展 [J]. 中国微创外科杂志, 2017, 17(4): 364-367.
[11] 兰云竹, 毛熙光. 宫颈癌盆腔淋巴结切除术后淋巴囊肿形成的探讨 [J]. 中国临床医生杂志, 2016, 2: 94-97.
[12] Tam K F, Lam K W, Chan K K, et al. Natural history of pelvic lymphocysts as observed by ultrasonography after bilateral pelvic lymphadenectomy [J]. Ultrasound Obstet Gynecol, 2008, 32(1): 87-90.
[13] Weinberger V, Fischerova D, Semeradova I, et al. Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy [J]. Taiwan J Obstet Gynecol, 2019, 58(2): 266-272.
[14] Volpi L, Sozzi G, Capozzi V A, et al. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience [J]. Int J Gynecol Cancer, 2019, 29(2): 312-319.
[15] Petru E, Tamussino K, Lahousen M, et al. Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer [J]. Am J Obstet Gynecol, 1989, 161(4): 937-941.
[16] 潘明霞. 子宫内膜癌术后盆腔淋巴囊肿危险因素分析 [J]. 中国实用妇科与产科杂志, 2017, 33(4): 428-432.
[17] 张 秦. 妇科恶性肿瘤盆腔淋巴结清扫术中淋巴管结扎不同方式对术后淋巴囊肿形成的影响 [J]. 肿瘤学杂志, 2014, 1: 15-18.
[18] 张海波. 高频电刀和超声刀在腹腔镜下宫颈癌手术中的应用价值研究 [J]. 中国实用妇科与产科杂志, 2017, 33(4): 390-394.
[19] Ghezzi F, Uccella S, Cromi A, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging [J]. Ann Surg Oncol, 2012, 19(1): 259-267.
[20] Bogani G, Borghi C, Ditto A, et al. Impact of surgical route in influencing the risk of lymphatic complications after ovarian cancer staging [J]. J Minim Invasive Gynecol, 2017, 24(5): 739-746.
[21] Suzuki M, Ohwada M, Sato I. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial "no-closure" for ovarian and endometrial cancers [J]. J Surg Oncol, 1998, 68(3): 149-152.
[22] Kim Y H, Shin H J, Ju W, et al. Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study [J]. J Gynecol Oncol, 2017, 28(3): e37.
[23] Grimm C, Polterauer S, Helmy-bader S, et al. A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial [J]. Gynecol Oncol, 2018, 149(1): 140-145.
[24] 董 萌. 妇科恶性肿瘤术后盆腔淋巴囊肿的防治 [J]. 中国临床解剖学杂志, 2018, 36(6): 714-716.
[25] 姚远洋. 妇科肿瘤腹膜后淋巴结切除术后淋巴囊肿形成的相关因素分析 [J]. 现代妇产科进展, 2013, 22(1):32-35.
[26] Charoenkwan K, Kietpeerakool C. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies [J]. Cochrane Database Syst Rev, 2017, 6(CD007387.
[27] Lindqvist E, Wedin M, Fredrikson M, et al. Lymphedema after treatment for endometrial cancer-a review of prevalence and risk factors [J]. Eur J Obstet Gynecol Reprod Biol, 2017, 211:112-121.
[28] Yamamoto R, Saitoh T, Kusaka T, et al. Prevention of lymphocyst formation following systematic lymphadenectomy [J]. Jpn J Clin Oncol, 2000, 30(9): 397-400.
[29] Kim W T, Ham W S, Koo K C, et al. Efficacy of octreotide for management of lymphorrhea after pelvic lymph node dissection in radical prostatectomy [J]. Urology, 2010, 76(2): 398-401.
[30] Weinberger V, Minar L, Felsinger M, et al.Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy in gynecological malignancies[J]. Ceska Gynekol, 82(2): 92-99.
[31] Golriz M, Klauss M, Zeier M, et al. Prevention and management of lymphocele formation following kidney transplantation [J]. Transplantation Reviews, 2017, 31(2): 100-105.
[32] Lucewicz A, Wong G, Lam V W, et al. Management of primary symptomatic lymphocele after kidney transplantation: a systematic review [J]. Transplantation, 2011, 92(6): 663-673.
[33] Uyulmaz S, Puippe G, Buyukakyuz N, et al. Sclerotherapy with OK-432 for the treatment of symptomatic lymphocele after lymph node dissection: a retrospective comparative cohort study [J]. Ann Plast Surg, 2020, 6:117.